Related Experiment Video
Updated: Sep 9, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic shock: a review of contemporary approaches and ongoing challenges
Lea R Goren1, Xuan Ding1, Maeve Jones-O'Connor1
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Insights
Cardiogenic shock (CS) management is complex. This review covers CS definition, pathophysiology, and evidence-based treatments like revascularization and microaxial flow pumps, highlighting knowledge gaps and ongoing trials.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a critical condition of inadequate cardiac output leading to organ failure.
- Understanding CS heterogeneity and classification is crucial for effective management.
Purpose of the Study:
- To review the definition, pathophysiology, classification, and management of cardiogenic shock.
- To highlight recent advances and evidence-based therapeutic approaches for CS.
- To identify current evidence gaps and ongoing trials in CS management.
Main Methods:
- Literature review focusing on cardiogenic shock.
- Analysis of recent advances in CS phenotypic heterogeneity and classification.
- Evaluation of evidence-based therapeutic interventions and mechanical circulatory support (MCS) devices.
Main Results:
- Emergent revascularization and microaxial flow pumps show survival benefits in specific CS cases (e.g., STEMI).
- Evidence for other medical therapies and MCS devices in CS remains limited.
- Significant gaps in evidence exist, with ongoing trials poised to inform future clinical practice.
Conclusions:
- Effective cardiogenic shock management requires understanding its complex pathophysiology and heterogeneity.
- Evidence-based treatments, while limited, offer survival benefits in select CS populations.
- Further research and ongoing clinical trials are essential to refine CS treatment strategies.
Abstract:
Cardiogenic shock (CS) is a complex condition characterized by insufficient cardiac output, tissue hypoperfusion, and life-threatening organ failure. In this review, we describe the definition, pathophysiology, classification, and approach to management in CS. We highlight recent advances in understanding the phenotypic heterogeneity and classification of CS. Then, we describe the limited, evidence-based, therapeutic approaches demonstrating survival benefit, including emergent revascularization of the culprit vessel in acute myocardial infarction related CS, and the use of a microaxial flow pumps in those with ST-segment elevation myocardial infarctions and CS. We also detail the limited evidence for other interventions, including medical therapies and other mechanical circulatory support (MCS) devices. Importantly, we highlight the current gaps in evidence and key ongoing trials that might inform the management of clinicians caring for patients with CS.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

